Dai-Ichi Karkaria Limited, a active public limited company, was established on 13 May 1960 in Mumbai, Maharashtra, India. Engaging in specialty chemicals within the manufacturing sector, it holds CIN: L24100MH1960PLC011681. Registered under ROC Roc Mumbai. it is listed on BSE: 526821. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹7.45 Cr.
Formerly known as Dai-Ichi Karkaria Private Limited. It upholds a compliant status. In 2023, it reported revenue of ₹190.38 Cr and a net worth of ₹147.93 Cr. Employing 179 professional, Its leadership includes Adi Hirji Jehangir (Director), Meher Firoze Vakil (Managing Director), Ashok Vishwanath Hiremath (Director). Past directors included Cyrus Adi Bagwadia, Keki Manchersha Elavia, Jehangir Hirji Cawasji Jehangir. It holds ₹26.00 Cr open charges and ₹248.28 Cr settled loans. Its latest AGM occurred on 20 August 2025, with the balance sheet filed on 31 March 2025. It is based at Liberty Bldg Sir Vithaldasthakckersey Marg, Mumbai, Maharashtra, 400020.
L24100MH1960PLC011681
011681
13 May 1960
₹10.00 Cr
₹7.45 Cr
Roc Mumbai
Listed (BSE: 526821)
Active
Explore comprehensive insights into Dai-Ichi Karkaria Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Adi Hirji Jehangir | Director | 19 Feb 1986 | Current |
| Meher Firoze Vakil | Managing Director | 01 Apr 2019 | Current |
| Ashok Vishwanath Hiremath | Director | 09 Sep 2020 | Current |
| Behram Maneck Sorabji | Director | 11 Aug 2023 | Current |
| Shernaz Firoze Vakil | Whole-Time Director | 26 Feb 1979 | Current |
| Srinivasan Vishwanathan | Director | 23 Jan 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 21 Sep 2023 | Past |
| Pramod Abcsdd | Additional Director | 21 Jul 2011 | Past |
| Pramod Abcsdd | Director | 16 Jan 2015 | Past |
| Pramod Abcsdd | Additional Director | 04 Sep 2008 | Past |
| Pramod Abcsdd | Director | 31 May 2013 | Past |
| Pramod Abcsdd | Whole-Time Director | 01 Apr 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Dai-Ichi Karkaria Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 48.83% increase. The company also saw a substantial improvement in profitability, with a 211.4% increase in profit. The company's net worth Soared by an impressive increase of 14.28%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Dai-Ichi Karkaria had a promoter holding of 63.88% and a public holding of 36.12%. The company had 1 Subsidiary and 1 Joint Venture. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹260,000,000.00
₹2,482,837,607.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Dec 2016 | Axis Bank Limited | ₹26.00 Cr | Open |
| 29 Mar 2022 | Axis Bank Limited | ₹2.80 Cr | Satisfied |
| 22 Nov 2019 | Axis Bank Limited | ₹10.00 Cr | Satisfied |
| 22 May 2017 | Hdfc Bank Limited | ₹47.00 Cr | Satisfied |
| 01 Jan 2016 | Kotak Mahindra Bank Limited | ₹12.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Dai-Ichi Karkaria has a workforce of 179 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Dai-Ichi Karkaria, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dai-Ichi Karkaria's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Dai-Ichi Karkaria Limited last Annual general meeting of members was held on 20 Aug 2025 as per latest MCA records. was completed.
The activity A charge registered on 29 Mar 2022 via Charge ID 100557061 with Axis Bank Limited was fully satisfied on 30 Apr 2025. was completed.
Dai-Ichi Karkaria Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.
Progress on Srinivasan Vishwanathan was appointed as a Director was appointed as a Director on 23 Jan 2025 & has been associated with this company since 10 months 2 days . was documented.
A charge with Axis Bank Limited of Rs. 26.00 Cr registered on 19 Dec 2016 with Charge ID 100071501 was modified on 26 Apr 2024. was recorded as a recent event.
Progress on Behram Maneck Sorabji was appointed as a Director was appointed as a Director on 11 Aug 2023 & has been associated with this company since 2 years 3 months . was documented.
When you trust blindly, you might end up paying $385 million. Daiichi bought Ranbaxy in 2008 for $4.6 billion, but soon faced problems with FDA. Lesson learned: trust but verify. Don't fall in love with your target, it can cloud your judgment. Choose a partner wisely, like Starbucks did with Tatas. Define your purpose carefully, Ranbaxy's focus on profit damaged its reputation. Quality cannot be injected, it must be built in. Daiichi avoided sunk cost fallacy and sold Ranbaxy to Sun Pharma. Valuable business lessons learned..
Singapore International Arbitration Centre says Malvinder and Shivinder Singh concealed facts from Japanese pharma major Daiichi Sankyo at the time of selling their stake in 2008.
The CIN of Dai-Ichi Karkaria Limited is L24100MH1960PLC011681.
Dai-Ichi Karkaria Limited is headquartered at Liberty Bldg Sir Vithaldasthakckersey Marg, Mumbai, Maharashtra, 400020.
Dai-Ichi Karkaria Limited was incorporated on 13 May 1960.
The current directors of Dai-Ichi Karkaria Limited are
The primary industry of Dai-Ichi Karkaria Limited is Manufacturing.
Dai-Ichi Karkaria Limited is listed. It is listed on BSE: 526821.
The authorized capital of Dai-Ichi Karkaria Limited is ₹10.00 Cr, and the paid-up capital is ₹7.45 Cr.
The compliance status of Dai-Ichi Karkaria Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX